Related references
Note: Only part of the references are listed.High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non- small- cell lung cancer
E. Pailler et al.
ANNALS OF ONCOLOGY (2015)
Serial blood-based analysis of AR-V7 in men with advanced prostate cancer
M. Nakazawa et al.
ANNALS OF ONCOLOGY (2015)
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients
Mark Thalgott et al.
BMC CANCER (2015)
Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents
M. Crespo et al.
BRITISH JOURNAL OF CANCER (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2015)
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew K. H. Hong et al.
NATURE COMMUNICATIONS (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Shiyang Wu et al.
PLOS ONE (2015)
Circulating tumour cells-monitoring treatment response in prostate cancer
David T. Miyamoto et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Prostate Cancer Ki-67 (MIB-1) Expression, Perineural Invasion, and Gleason Score as Biopsy-Based Predictors of Prostate Cancer Mortality: The Mayo Model
Matthew K. Tollefson et al.
MAYO CLINIC PROCEEDINGS (2014)
Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells
Angel E. Dago et al.
PLOS ONE (2014)
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
G. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
Andrew J. Armstrong et al.
EUROPEAN UROLOGY (2012)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
A. Lecharpentier et al.
BRITISH JOURNAL OF CANCER (2011)
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F. Farace et al.
BRITISH JOURNAL OF CANCER (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
Li-Yan Khor et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity
K. Fizazi et al.
ANNALS OF ONCOLOGY (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
